表紙
市場調查報告書

手術用人工血管市場 - 成長,趨勢,及預測(2019-2024)

Vascular Graft Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 871390
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
Back to Top
手術用人工血管市場 - 成長,趨勢,及預測(2019-2024) Vascular Graft Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年05月01日內容資訊: 英文 114 Pages
簡介

全球手術用人工血管市場在2019年-2024年之間預測將以5.7%的年複合成長率成長。

本報告提供全球手術用人工血管市場的相關調查,市場概況及成長要素、阻礙因素,各產品、用途、原料、地區的市場分析,競爭情形,主要企業的簡介等資訊彙整。

目錄

第1章 簡介

  • 研究成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 文明病的罹患率增加
    • 支架材料和手術用人工血管的設計的技術性進步
  • 市場阻礙因素
    • 不利的償付方案
    • 移植失敗伴隨的高風險
  • 波特五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
    • 血液透析機接入移植
    • 血管內血管支架
    • 末稍血管移植
    • 冠狀動脈側道術
  • 各用途
    • 動脈瘤
    • 腎功能衰竭
    • 血管閉塞
    • 冠狀動脈疾病
    • 其他的用途
  • 各原料
    • 合成原料
    • 生物學的原料
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 有競爭力的風景

  • 企業簡介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Bard Peripheral Vascular Inc. (BD)
    • Cardinal Health (Cordis)
    • Cook Medical
    • Cryolife
    • Getinge Group
    • LeMaitre Vascular Inc
    • Medtronic PLC
    • Terumo Corporation
    • W.L. Gore & Associates Inc

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 62301

Market Overview

The global Vascular Graft market is expected to register a CAGR of 5.7% over the forecast period. Key factors contributing to the market growth are rising prevalence of cardiac diseases, increasing prevalence of diabetes, and end-stage renal diseases, coronary artery disease (CAD), hypertension and cardiac aneurysms. Apart from the mentioned factors, genetic and hereditary factors, unhealthy lifestyle, alcohol consumption, tobacco smoking, etc., are expected to increase the demand for vascular grafts over the period. Low reimbursement rate and rising out-of-pocket expenses in an emerging economy can restrain market growth.

Scope of the Report

Vascular grafts are medical devices which are used in vascular bypass procedures to direct the blood flow from one area to another by reconnecting the blood vessels. The report covers revenue generated by the sale of hemodialysis access grafts, endovascular stent grafts, peripheral vascular grafts, and coronary artery bypass grafts.

Key Market Trends

Hemodialysis Access Graft Segment is Expected to Register Robust Growth

The global prevalence of end-stage renal diseases (ESRD) is increasing at a significant rate, as chronic kidney diseases (CKD) may develop over many years leading to ESRD. nearly Two million people worldwide suffer from ESRD, and the number of patients diagnosed with the disease continues to increase at a rate of 5-7% per year.

The aging population is further aggravating the increasing prevalence of ESRD. According to the Ministry of Health of the People's Republic of China's statistics the prevalence of chronic kidney disease among females in the Chinese general population increases from 7.4% among those aged 18-39 years to an estimated 18.0% and 24.2% among those aged 60-69 and 70 years respectively.

Apart from kidney transplant dialysis is the primary management option for patients with ESRD. Vascular access is considered as the lifeline of a patient on hemodialysis for better treatment and safety. For long-term use, majorly, two types of vascular access are designed: arteriovenous (AV) fistula and the AV graft, while the venous catheter is designed for short-term use. AV fistula is a direct connection of an artery to a vein made by a surgeon, whereas in AV graft, a plastic tube is used to connect an artery to a vein.

North America is Expected to Retain Largest Market Share During the Forecast Period

North America dominates the vascular grafts market. North America maintained its dominant share due to the high prevalence rate of diabetes, cardiovascular diseases, and chronic kidney disease. Presence of reimbursement coverage and availability of state-of-the-art healthcare infrastructure are driving the growth of this market in North America. Asia-Pacific is anticipated to show the fastest growth during the forecast period due to increasing incidences of cardiovascular disease & diabetes and improving healthcare infrastructure.

Competitive Landscape

Key players in the market include Abbott Laboratories, B. Braun Melsungen AG, Bard Peripheral Vascular Inc. (BD), Cardinal Health (Cordis), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic plc, Terumo Medical Corporation, and W.L. Gore & Associates Inc among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Lifestyle-related Disorders
    • 4.2.2 Technological Advancements in the Scaffold Material and Design of Vascular Grafts
  • 4.3 Market Restraints
    • 4.3.1 Unfavorable Reimbursement Scenario
    • 4.3.2 High Risk Associated with Graft Failures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Hemodialysis Access Graft
    • 5.1.2 Endovascular Stent Graft
    • 5.1.3 Peripheral Vascular Graft
    • 5.1.4 Coronary Artery By-pass Graft
  • 5.2 By Application
    • 5.2.1 Aneurysms
    • 5.2.2 Kidney Failure
    • 5.2.3 Vascular Occlusion
    • 5.2.4 Coronary Artery Diseases
    • 5.2.5 Other Applications
  • 5.3 By Raw Material
    • 5.3.1 Synthetic Raw Material
    • 5.3.2 Biological Raw Material
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Bard Peripheral Vascular Inc. (BD)
    • 6.1.4 Cardinal Health (Cordis)
    • 6.1.5 Cook Medical
    • 6.1.6 Cryolife
    • 6.1.7 Getinge Group
    • 6.1.8 LeMaitre Vascular Inc
    • 6.1.9 Medtronic PLC
    • 6.1.10 Terumo Medical Corporation
    • 6.1.11 W.L. Gore & Associates Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top